The U.S. Food and Drug Administration on Wednesday approved a second oral GLP-1 medication, giving adults eligible for weight ...

The popular GLP-1 weight-loss drug will be available via a subscription program designed to lower costs for self-pay patients.

The rapid rise of GLP-1 medications like Ozempic and Wegovy has reshaped the weight loss landscape, with prescriptions in the U.S. surging more than 300% in recent years, particularly among women over ...

A new program helps patients safely transition off GLP-1 medications while maintaining results through nutrition, ...

The U.S. Food and Drug Administration (FDA) has approved a once-daily GLP-1 pill for weight loss called orforglipron, and ...

Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...

In late March 2026, Hims & Hers Health, Inc. announced a renewed collaboration with Novo Nordisk to offer a broad range of FDA-approved GLP-1 medications, including Wegovy injections and the only ...

A new daily pill to help with weight loss has been approved by the U.S. Food and Drug Administration (FDA), and it moved ...

Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.

A UAB-developed automated online weight loss program helps cancer survivors achieve the highest weight loss ever reported for a digital intervention, improving cardiometabolic health, diet quality and ...

Weight-loss programs abound on the internet, from customized plans sold by influencers lacking credentials to subscription services offering access to GLP-1s and other medications. It can be tricky to ...

Yo-yo dieting has often been linked to a cycle of weight loss and regain, but new research suggests there may actually be ...